Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.1500
-0.0050 (-3.23%)
Jul 31, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 294.17 million as of July 31, 2025. Its market cap has decreased by -57.23% in one year.
Market Cap
294.17M
Enterprise Value
246.60M
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 294.17M, an increase of 2,298.55%. That is a compound annual growth rate of 42.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 294.17M | -62.79% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | 121.64M | 52.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.27B |
| Pro Medicus | 33.76B |
| Cochlear | 20.72B |
| Sonic Healthcare | 13.93B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 6.95B |
| Ansell | 4.38B |
| Mesoblast | 3.19B |